A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
Zong, Hui-fang, Li, Xi, Han, Lei, Wang, Lei, Liu, Jun-jun, Yue, Ya-li, Chen, Jie, Ke, Yong, Jiang, Hua, Xie, Yue-qing, Zhang, Bao-hong, Zhu, Jian-wei
Published in Acta pharmacologica Sinica (01.08.2024)
Published in Acta pharmacologica Sinica (01.08.2024)
Get full text
Journal Article
Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktails
Ma, Hang, Zong, Hui-fang, Liu, Jun-jun, Yue, Ya-li, Ke, Yong, Liao, Yun-ji, Tang, Hao-neng, Wang, Lei, Wang, Shu-sheng, Yuan, Yun-sheng, Wu, Ming-yuan, Bian, Yan-lin, Zhang, Bao-hong, Yin, Hai-yang, Jiang, Hua, Sun, Tao, Han, Lei, Xie, Yue-qing, Zhu, Jian-wei
Published in Acta pharmacologica Sinica (01.07.2023)
Published in Acta pharmacologica Sinica (01.07.2023)
Get full text
Journal Article
T cell-redirecting antibody for treatment of solid tumors via targeting mesothelin
Liu, Jun-jun, Pan, Zhi-di, Yue, Ya-li, Wang, Shu-sheng, Chen, Jie, Jiang, Hua, Zhang, Bao-hong, Wu, Ming-yuan, Yuan, Yun-sheng, Bian, Yan-lin, Yin, Hai-yang, Wang, Lei, Li, Jun-yan, Gilly, John, Xie, Yue-qing, Zhu, Jian-wei
Published in Acta pharmacologica Sinica (01.10.2024)
Published in Acta pharmacologica Sinica (01.10.2024)
Get full text
Journal Article